Maximum quantity allowed is 999
Please select the quantity
CAS RN: 61413-54-5 | Product Number: R0110
Rolipram
Purity: >98.0%(HPLC)
Synonyms:
- 4-[3-(Cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinone
Product Documents:
Size | Unit Price | Same Day | 2-3 Business Days |
---|---|---|---|
50MG |
$110.00
|
28 | Contact Us |
250MG |
$332.00
|
4 | Contact Us |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
Product Number | R0110 |
Purity / Analysis Method | >98.0%(HPLC) |
Molecular Formula / Molecular Weight | C__1__6H__2__1NO__3 = 275.35 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Frozen (-20°C) |
Condition to Avoid | Heat Sensitive |
Packaging and Container | 250MG-Glass Bottle with Plastic Insert (View image), 50MG-Glass Bottle with Plastic Insert (View image) |
CAS RN | 61413-54-5 |
Reaxys Registry Number | 1588548 |
PubChem Substance ID | 253659657 |
Merck Index (14) | 8251 |
MDL Number | MFCD00270906 |
Specifications
Appearance | White to Orange to Green powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Melting point | 130.0 to 134.0 °C |
Properties (reference)
Melting Point | 132 °C |
GHS
Related Laws:
RTECS# | UY5749237 |
Transport Information:
H.S.code* | 2933.79-000 |
Application
Rolipram: A Selective PDE4 Inhibitor
Rolipram is a selective inhibitor of phosphodiesterases 4 (PDE4s) originally developed as an antidepressant agent in 1990s, but fell out of favor because of its undesirable gastrointestinal side effects. Nowadays, rolipram continues to be used in research as a PDE4 inhibitor. PDE4s are responsible for hydrolysis of the cyclic nucleotides cAMP [A2381] and cGMP to 5’-AMP [A0158] and 5’-GMP [G0338], particularly in nerve and immune cells. The inhibition of PDE4s by rolipram induces the elevation of intracellular cAMP concentration. Consequences rolipram-induced elevation of cAMP suppress expression of proinflammatory cytokines and other mediators of inflammation. Rolipram has been reported as a drug for the treatment of autoimmune diseases, Alzheimer's disease, cognitive enhancement, and respiratory diseases like asthma and COPD. Rolipram is a racemic compound, and (R)-rolipram [R0182] is more potent than (S)-rolipram [R0183] as a PDE4 inhibitor. (The product is for research purpose only.)
References
- The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis
- Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory
- The antidepressant and antiinflammatory effects of rolipram in the central nervous system (a review)
- Effects of a phosphodiesterase IV inhibitor rolipram on microsphere embolism-induced defects in memory function and cerebral cyclic AMP signal transduction system in rats
- Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment
- Phosphodiesterases as Therapeutic Targets for Alzheimer's Disease (a review)
PubMed Literature
Articles/Brochures
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.